These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33146343)

  • 1. Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects.
    Durante Í; Dos Santos RG; Bouso JC; Hallak JE
    Braz J Psychiatry; 2021; 43(4):362-369. PubMed ID: 33146343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.
    Lawn W; Hallak JE; Crippa JA; Dos Santos R; Porffy L; Barratt MJ; Ferris JA; Winstock AR; Morgan CJA
    Sci Rep; 2017 Nov; 7(1):15201. PubMed ID: 29123145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
    Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
    Houle SKD; Evans D; Carter CA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Malcolm BJ; Lee KC
    Ment Health Clin; 2017 Jan; 7(1):39-45. PubMed ID: 29955496
    [No Abstract]   [Full Text] [Related]  

  • 8. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.
    Murphy-Beiner A; Soar K
    Psychopharmacology (Berl); 2020 Apr; 237(4):1161-1169. PubMed ID: 31927605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series.
    Gómez-Sousa M; Jiménez-Garrido DF; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):163-171. PubMed ID: 33606432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS.
    Tavares L; Monedeiro F; Bordin DM; De Martinis BS
    J Anal Toxicol; 2020 Jul; 44(6):601-609. PubMed ID: 32103256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey.
    Daldegan-Bueno D; Révész D; Morais PR; Barbosa PCR; Maia LO
    Subst Use Misuse; 2022; 57(7):1072-1081. PubMed ID: 35466853
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
    Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
    Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ayahuasca's therapeutic potential: What we know - and what not.
    Maia LO; Daldegan-Bueno D; Wießner I; Araujo DB; Tófoli LF
    Eur Neuropsychopharmacol; 2023 Jan; 66():45-61. PubMed ID: 36368095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life.
    Kaasik H; Kreegipuu K
    J Psychoactive Drugs; 2020; 52(3):255-263. PubMed ID: 32299306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study.
    Maia LO; Daldegan-Bueno D; Tófoli LF
    J Psychoactive Drugs; 2021; 53(3):272-282. PubMed ID: 33287690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
    Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
    J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
    Sanches RF; de Lima Osório F; Dos Santos RG; Macedo LR; Maia-de-Oliveira JP; Wichert-Ana L; de Araujo DB; Riba J; Crippa JA; Hallak JE
    J Clin Psychopharmacol; 2016 Feb; 36(1):77-81. PubMed ID: 26650973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.